Carmen Cracknell2 min read
Hameed Shuja3 min read
Martina Lindberg, Vasilka Lalevska1 min read
Vlada Gurvich37 min listen
Jean Hurley3 min read
Julie DiMauro43 min listen

Key themes and emerging questions in regulation.

Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.
Amélie Chollet | CMS, Dr. Roland Wiring3 min read